Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.30p +2.02% 15.15p 169,848 16:26:39
Bid Price Offer Price High Price Low Price Open Price
15.00p 15.30p 15.15p 14.85p 14.85p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.36 -4.84 -3.23 31.0

Futura Medical (FUM) Latest News

More Futura Medical News
Futura Medical Takeover Rumours

Futura Medical (FUM) Share Charts

1 Year Futura Medical Chart

1 Year Futura Medical Chart

1 Month Futura Medical Chart

1 Month Futura Medical Chart

Intraday Futura Medical Chart

Intraday Futura Medical Chart

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date Time Title Posts
20/3/201912:23FUTURA a winner for 20155,221
18/2/201909:30one million1
21/1/201909:54www.bluediamondcondom.com59
02/12/201613:27FUM delivering on sex,pain and rock'n'roll11,414
21/6/201607:43fum reality1

Add a New Thread

Futura Medical (FUM) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-03-22 16:26:1515.303,196488.86O
2019-03-22 15:07:5615.0519,1612,883.73O
2019-03-22 14:32:0015.05406.02O
2019-03-22 14:07:1515.057,1471,075.62O
2019-03-22 12:23:2515.007,5001,125.00O
View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

DateSubject
22/3/2019
08:20
Futura Medical Daily Update: Futura Medical is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 14.85p.
Futura Medical has a 4 week average price of 11.63p and a 12 week average price of 5.95p.
The 1 year high share price is 40.50p while the 1 year low share price is currently 5.50p.
There are currently 204,660,267 shares in issue and the average daily traded volume is 191,389 shares. The market capitalisation of Futura Medical is £31,006,030.45.
07/3/2019
12:18
j777j: Not only is the product patented but we are awaiting news on further extensions to the patents.The second half of this year is going to get pretty exciting.Will likely all start with the UK regulatory approval for TPR100 the first pain gel.I would not be at all surprised when the share price quote is 150/155p instead of 15/15.5p.
06/3/2019
11:16
martinelwick: There cannot be a more volatile share on AIM.There is no news but we see 15% swings in the share price on a daily basis.This is MM manipulation and many get shafted!
22/1/2019
05:52
j777j: Umm let's see. Oh yes,we have just passed Q1 of the Med2002 phase 3 trials. Which if successful, could see the most compelling competition to Viagra and Cialis in 20 years. A treatment that not only works much faster,but is applied topically making for a significantly safer product. 18 people died in the UK alone last year from taking Viagra. Med2002 peak sales are estimated at around $1.4 billion annually. A "blockbuster drug" is defined as achieving $1billion sales annually. The safety data trial( Pharmacokinetic study) has already passed with flying colours. Secondly Fum is waiting for UK regulatory approval for it's topical pain gel which was submitted last july The topical pain gel market size is estimated to be three times larger than the ED market in the next 5 years.Mainly boosted by ageing populations. However and equally important is the increasing evidence of the risks to taking NSAIDS orally. So a topically applied pain gel is very compelling,especially when you realise Futura's products not only act much faster but because of their penetration, doses can be reduced from 4 times a day to just one or two. Finally last September the co managed to achieve a two year shelf life for its erectogenic condom . This is a game.changer and we can expect further news on this at anytime. In summary,after 17 years the ducks are finally lining up for the co. I expect the share price to at least 10 bag from these levels.
14/1/2019
11:00
bioking: If you guys want the stock to make bigger moves then please put your shares on high GTC sell order like 50p this helps to prevent your shares from being shorted and more important your shares will not be available on the market so if all shareholders doing that then it would help this stock to make bigger jumps in share price on good news. thank you hxxp://www.contracts-for-difference.com/Borrowing-lending-shares.html Q:What can you do to prevent your shares holdings from being shorted? A: Now what can the average personal investor do to stop their own shares being shorted, as believe me your own broker, if approached, WILL sell your own shares that they hold on your behalf as a nominee account. There are two things you can do, the first is to certificate them but this is not obviously to everyone’s advantage but the alternative solution is simple. All you do is to phone your broker and put an order in saying that you wish to place your shares for sale at, for arguments sake, double today’s price. As they are ‘on order’ they cannot be lent out by your broker and in turn you are reducing the amount of ‘free shares’ out there that can be used for shorting purposes. And don’t forget to move your limit order up when the price starts to recover, then, that way your shares can’t be shorted – not much but helps :D. Although an individual personal investor will not normally have enough shares to halt a concerted shorting attack, if a large number of holders did this it would reduce the overall amount of shares that they could get their hands on. In my opinion well worth doing if not only for the knowledge that your own shares cannot and will not be used in a short attack against the very share that you own.
09/1/2019
16:11
lbo: James Barder should be investigated for all the false public statements he has made. He promised in a Stockcube interview (3 minutes in http://youtu.be/IPxRKqMPfeQ ) and in previous Futura results a deal on Med2002 that involved some "punchy numbers" before Phase 3."Discussions towards the out-licensing of MED2002 advanced materially during the year and, as previously stated, we believe that a commercial out-licensing agreement will be announced in the first half of this year"No deal materialised! And then he oversaw the share price collapse from 40p to 7p and a massive dilution which he claimed would add shareholder value which after the share price falls and dilution is mathematically impossible
09/1/2019
15:14
lbo: Such a fantastic opportunity that the partner who was supposedly in advanced discussions in March 2018 when the share price was 40p and then completely disappeared and now even at the supposed bargain of 10p has not reappeared with a bid. Never mind even buying shares in the 7p fundraising which was undersubscribed.Mr Barder then backtracked in September and October 2018 and said that raising funds and carrying out phase 3 would add 50% more value to the Med2002 licensing deal yet all the while the share price collapsed from 40p to 7p. So Futura management now need to add 400% in share price value to just get it back to the share price where they claimed they were in advanced discussions with a partner and then claimed by raising funds and completing phase 3 they would add 50% more value to the licensing deal.
08/1/2019
09:58
j777j: Put it this way if you were Pfizer who own viagra and some little upstart had the potential to seriously disrupt your multi billion dollar cash cow what would you do?In my experience the Americans play dirty and I would not be at all surprised if their hands are behind this.So as that did not work because Fum got funded,two optionsSign a licensing deal.Buy out the co.If the latter they will want to pay as little as possible so trashing the share price to soften investors up would be a strategy not unknown.
02/3/2018
15:12
j777j: Something for the weekend courtesy Gold dust on lse goldust881,179 posts Potential share price for Futura ? What is the future for Futura's share price. I have detailed below, from info in the results and more particularly from the webcast presentations what news Futura expects to announce during 2018, of which there is quite a lot that will affect the share price. MED2000-Securing of major commercial deal. CSD500-Reasignment of Rights for most of Europe and USA CSD500-Launch in 6 more countries and possibly up to 13. TPR100 & TIB200 -securing of further deals in USA/Europe. So what about the share price. Clearly there is massive potential if all the products end up all on sale at once but leading up to that point I think that announcements of each of the above this year will increase the share price as each one will confirm that progress is being made, some more than others. Clearly with any deal being announced one can expect upfront deal fees which can be substantial and this is what Futura expect as they stated at the results seminar they have no need to raise further cash. Looking at other company deals in these sectors the total upfront fees could easily be in the ?25-40 million range. So what could Futura be worth in a couple of years time. From global sales figures provided by Futura we have the following potential for Futura's market share and earnings. MED 2000 ($1 billion per annum)= ?800 million say @5% royalty is ?40 million pa TPR100 & TIB200 (1/2 billion per annum)=?400 million say @5% royalty is ?20 million pa CSD500 @10% market share of a $6billion pa market is $600 million=?450 million @ 5% royalty rate is ?9 million per annum. That totals to ?69 million per annum. That's the potential. So with an income of that size with minimal overheads the company on a p/e of 10 % would be valued at ?690 million or ?5.56 per share Current company value @ 47p today is appx 57million So the potential is 10 times the current share price. With lots of news this year we could easily see the share price double up with the newsflow and a big bucks rise coming after the current MED 2000 trial results due shortly. News may come at any time so it's a buy at this price now in my view with results due out on 14th March. If any of one of these major deals comes of the share price would double.. Clearly another investor who has done the maths and sees a ten bagger from here.
07/6/2017
08:33
mikethebike4: james 'There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here. - I have seen this written so many times over the last few years - I will be so shocked when it actually happens I will probably climax on the spot without the aid of Blue Diamond ! - 18 months product is already available from TTK in Asia - why they did not submit for regulatory approval at the same time in Europe I do not know - however I am expecting an announcement by the BoD so that the AGM is not a 'damp squib' MTB4
06/6/2017
21:59
jamesd888: There will also be many new launches of the condom within the next 6 months which will help with the profile and see FUM Share price rocket....so the next 6 months are most interesting and the best time to be in here.
Futura Medical share price data is direct from the London Stock Exchange
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190323 04:26:51